MeSH Browser

MeSH Supplementary: nilotinib
Unique ID: C498826
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C498826
Entry Term(s): 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide; AMN 107; AMN-107; AMN107; Tasigna; benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride (1:1); benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate; benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate (1:1:2); benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate (1:2:2); benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate (2:2:3); nilotinib dihydrochloride dihydrate; nilotinib hydrochloride; nilotinib hydrochloride anhydrous; nilotinib hydrochloride dihydrate; nilotinib hydrochloride hydrate; nilotinib hydrochloride monohydrate; nilotinib hydrochloride sesquihydrate
Pharm Action: Tyrosine Kinase Inhibitors
Registry Numbers: F41401512X; 0; 5JHU0N1R6K; FQV3UFL546; Y37S7HA3BC; K37N7BYX3X; WM15I3PF3G
Related Numbers: 5JHU0N1R6K; FQV3UFL546; K37N7BYX3X; WM15I3PF3G; Y37S7HA3BC
Heading Mapped to: *Pyrimidines
Frequency: 1374
Note: antineoplastic agent
Source: Cancer Cell 2005 Feb;7(2):117-9
Indexing Information: Protein-Tyrosine Kinases
Date of Entry: 2005/04/06
Revision Date: 2023/08/04

nilotinib Preferred

AMN107 Narrower

nilotinib hydrochloride hydrate Narrower

nilotinib hydrochloride sesquihydrate Narrower

nilotinib hydrochloride dihydrate Narrower

nilotinib hydrochloride anhydrous Narrower

nilotinib dihydrochloride dihydrate Narrower

nilotinib MeSH Supplementary Concept Data 2025